Comparison of mid-outcome among bare metal stent, atherectomy with or without drug-coated balloon angioplasty for femoropopliteal arterial occlusion

This study evaluated the outcomes of a bare metal stent (BMS), DCB alone, atherectomy plus a drug-coated balloon (AT + DCB) and AT alone for the treatment of femoropopliteal artery occlusion. Four groups were included in this retrospective cohort study: 119 patients underwent the BMS procedure, 89 p...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2024-01, Vol.14 (1), p.63-63, Article 63
Main Authors: Yang, Lin, Quan, Jianjun, Dong, Jian, Ding, Ningning, Han, Yang, Cong, Longlong, Lin, Yuhao, Liu, Jianlin
Format: Article
Language:English
Subjects:
692/1807
692/308
692/4019
692/499
692/699
Amputation
Angioplasty
Balloon treatment
Clinical outcomes
Cohort analysis
Contraindications
Dissection
Hospitals
Humanities and Social Sciences
Implants
Lasers
Lesions
Medical imaging
multidisciplinary
Occlusion
Patients
Restenosis
Science
Science (multidisciplinary)
Stents
Vascular occlusion
Vascular surgery
Veins & arteries
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study evaluated the outcomes of a bare metal stent (BMS), DCB alone, atherectomy plus a drug-coated balloon (AT + DCB) and AT alone for the treatment of femoropopliteal artery occlusion. Four groups were included in this retrospective cohort study: 119 patients underwent the BMS procedure, 89 patients underwent DCB alone, 52 patients underwent AT + DCB, and 61 patients underwent AT alone. Patients were followed-up at 1, 6, 12 and 24 months after the procedure, the clinical outcomes and complications were assessed, and the primary outcomes were primary patency and restenosis. AT + DCB showed a lower bailout stent, and BMS displayed a higher retrograde puncture, flow-limiting dissection and postdilation ( p  
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-023-50511-8